Takeda Pharmaceutical (TAK) Invested Capital (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Invested Capital of $27.7 billion for Q2 2026, down 2.96% year-over-year from $28.6 billion in Q2 2025, and down 10.92% quarter-over-quarter from $31.1 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Invested Capital (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Invested Capital history runs 9 years deep, the most recent figure standing at $27.7 billion for Q2 2026.
- In Q2 2026, Invested Capital fell 2.96% year-over-year to $27.7 billion; the TTM figure through Jun 2026 stood at $116.1 billion (down 2.24% YoY), while the FY2026 annual figure was $32.4 billion, up 9.41% from the prior year.
- Invested Capital for Q2 2026 stood at $27.7 billion, down from $31.1 billion in the prior quarter.
- The five-year high for Invested Capital was $37.4 billion in Q1 2022, with the low at $27.7 billion in Q4 2022.
- The 5-year median for Invested Capital is $30.3 billion (2022), against an average of $30.7 billion.
- The sharpest annual moves came in 2022 and 2024: Invested Capital retreated 25.57% in 2022, then rose 6.53% in 2024.
- Takeda Pharmaceutical's Invested Capital stood at $27.7 billion in 2022, then climbed by 4.83% to $29.0 billion in 2023, then increased by 6.53% to $30.9 billion in 2024, then decreased by 10.34% to $27.7 billion in 2025, then retreated by 0.06% to $27.7 billion in 2026.
- Business Quant data shows TAK's Invested Capital at $27.7 billion in Q2 2026, $31.1 billion in Q1 2026, and $27.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 630.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.73 Bn |
| Mar 31, 2026 | 31.13 Bn |
| Dec 31, 2025 | 27.75 Bn |
| Sep 30, 2025 | 29.53 Bn |
| Jun 30, 2025 | 28.58 Bn |
| Mar 31, 2025 | 29.60 Bn |
| Dec 31, 2024 | 30.95 Bn |
| Sep 30, 2024 | 29.68 Bn |
| Jun 30, 2024 | 32.39 Bn |
| Mar 31, 2024 | 32.68 Bn |
| Dec 31, 2023 | 29.05 Bn |
| Sep 30, 2023 | 30.50 Bn |
| Jun 30, 2023 | 31.60 Bn |
| Mar 31, 2023 | 33.13 Bn |
| Dec 31, 2022 | 27.71 Bn |
| Sep 30, 2022 | 30.18 Bn |
| Jun 30, 2022 | 33.41 Bn |
| Mar 31, 2022 | 37.39 Bn |
| Dec 31, 2021 | 37.23 Bn |
| Sep 30, 2021 | 36.49 Bn |